Schiffer E (2011) Urinary proteomics: ready for prime time in urological cancer diagnosis.
Future Med 8:81–94
Schmidt MA, Goodwin TJ (2013) Personalized medicine in human space flight: using Omics
based analyses to develop individualized countermeasures that enhance astronaut safety and
performance. Metabolomics 9:1134–1156
Shah AM, Mann DL (2011) In search of new therapeutic targets and strategies for heart failure:
recent advances in basic science. Lancet 378:704–712
Shao S, Guo T, Aebersold R (2015) Mass spectrometry-based proteomic quest for diabetes bio-
markers. Biochim Biophys Acta. doi:10.1016/j.bbapap.2014.12.012
Sharma V, Singh BP, Gaur SN, Pasha S, Arora N (2009) Bioinformatics and immunologic
investigation on B and T cell epitopes of Cur l 3, a major allergen of Curvularia lunata.
J Proteom Res 8:2650–2655
Silvestri A, Calvert V, Belluco C, Lipsky M, De Maria R, Deng J et al (2013) Protein pathway
activation mapping of colorectal metastatic progression reveals metastasis-specific network
alternations. Clin Exp Metastasis 30:309–316
Simo ́n-Sa ́nchez J, Schulte C, Bras JM, Sharma M, Gibbs JR et al (2009) Genome-wide association
study reveals genetic risk underlying Parkinson’s disease. Nat Genet 41:1308–1312
Smith LE, White MY (2014) The role of post-translational modifications in acute and
chronic cardiovascular disease. Proteomics Clin Appl 8:506–521
Sparre T, Larsen MR, Heding PE, Karlsen AE, Jensen ON, Pociot F (2005) Unraveling the
pathogenesis of type 1 diabetes with proteomics. Mol Cell Proteomics 4:441–457
Spienlli KJ, Taylor JK, Osterberg VR, Churchill MJ, Pollock E et al (2014) Presynaptic alpha-
synuclein aggregation in a mouse model of Parkinson’s disease. J Neurosci 34:2037–2050
Stehle F, Schulz K, Seliger B (2014) Towards defining biomarkers indicating resistances to
targeted therapies. Biochim Biophys Acta 1844:909–916
Sui W, Cui Z, Zhang R, Xue W, Ou M et al (2014) Comparative proteomic analysis of renal tissue
in IgA nephropathy with iTRAQ quantitative proteomics. Biomed Rep 2:793–798
Sundstena T, Ortsa ̈ter H (2009) Proteomics in diabetes research. Mol Cell Endocrinol 297:93–103
Taverna D, Pollins AC, Sindona G, Caprioli RM, Nanney LB (2014) Imaging mass spectrometry
for assessing cutaneous wound healing: analysis of pressure ulcers. J Proteome Res. doi:10.
1021/pr5010218(12/8/2014)
Thambisetty M, Simmons A, Hye A, Campbell J, Westman E et al (2011) Plasma biomarkers of
brain atrophy in Alzheimer’s disease. PLoS One. doi:10.1371/journal.pone.0028527
The Huntington’s Disease Collaborative Group (1993) A novel gene containing a trinucleotide
repeat that is expanded and unstable on Huntington’s disease chromosomes. Cell 72:971–983
van Ham TJ, Breitling R, Swetz MA, Nollen EAA (2009) Neurodegenerative diseases: lessons
from genome-wide screens in small model organisms. EMBO Mol Med 1:360–370
Varadchachary GR, Raber MN (2014) Cancer of unknown primary side. N Engl J Med 371:
757–765
Ve ́lez P, Garcı ́a A (2014) Platelet proteomics in cardiovascular diseases. Transl Proteomics.
doi:10.1016/j.trprot.2014.09.002
Vidal M, Cusick ME, Barabasi AL (2011) Interactome networks and human disease. Cell 144:
986–998
Voros S (2014) Leveraging next-generation phenotyping and pan-omics to identify novel bio-
markers and pharmaceutical targets for cardiovascular disease. Pers Med 11:239–242
Wang Y, Watres J, Leung ML, Unruh A, Roh W et al (2014) Clonal evolution in breast cancer
revealed by single nucleus genome sequencing. Nature 512:155–160
Wolfkuhle JD, Berg D, Langer R, Tran K, Illi J, Espina V et al (2012) Molecular analysis of HER2
signaling in human breast cancer by functional protein pathway activation mapping.
Clin Cancer Res 18:6426–6435
Xiong Y, Zhang Y, Iqbal J, Ke M, Wang Y et al (2014) Differential expression of synaptic proteins
in unilateral 6-OHDA lesioned rat model – a comparative proteomics approach. Proteomics
14:1808–1819
The Role of Proteomics in Personalized Medicine 217